DrugMar 6, 2024
Mesalamine Extended-Release Capsules, USP 500mg recall — FDA D-0350-2024
Failed Dissolution Specifications: Out of specification for dissolution.
Class IIFDA: OngoingSUN PHARMACEUTICAL INDUSTRIES Inc.
Latest records
Latest recalls — page 227
The newest recall records with useful source details are listed here.
VehicleMar 5, 2024
Nissan pretensioner recall — NHTSA campaign 24V176000
Nissan North America, Inc. (Nissan) is recalling certain 2024 Pathfinder and Infiniti QX60 vehicles. The lap belt pretensioner in the left-side front seat belt assembly may be improperly…
pretensionerNissan North America, Inc.
VehicleFeb 28, 2024
Rogue pretensioner recall — NHTSA campaign 24V156000
Nissan North America, Inc. (Nissan) is recalling certain 2023 Rogue vehicles. The driver and front passenger seat belt pretensioners may have been incorrectly manufactured, which can cause…
pretensionerNissan North America, Inc.
DrugFeb 28, 2024
Today The World Sustain Herbal Dietary Supplement recall — FDA D-0343-2024
Marketed Without An Approved NDA/ANDA: FDA analysis found this product to be tainted with undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual…
Class IFDA: OngoingToday The World
DrugFeb 28, 2024
Today The World SCHWINNNG Herbal Dietary Supplement recall — FDA D-0344-2024
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared nortadalafil, an ingredient found in FDA approved product for the treatment of male…
Class IFDA: OngoingToday The World
DrugFeb 28, 2024
Fosfomycin Tromethamine Granules for Oral Solution recall — FDA D-0339-2024
Failed Impurities/Degradation Specification: Out of specification for organic impurities
Class IIFDA: OngoingAscend Laboratories, LLC
DrugFeb 28, 2024
Adrenalin (epinephrine) Injection 1mg/mL, 1mL single dose vial recall — FDA D-0342-2024
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiration date listed on the Repack Pouch Label is incorrect.
Class IIFDA: CompletedHenry Schein Inc. and Glove Club HSI Gloves Inc.
DrugFeb 28, 2024
Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays - 16 g net fill recall — FDA D-0326-2024
CGMP Deviations: potential presence of Burkholderia cepacia complex
Class IIFDA: OngoingApotex Corp.
DrugFeb 28, 2024
Neptune Resources Neptune's Fix, Tianeptine Elixir, Fast Acting, 0.338 fl oz (10 mL) bottle recall — FDA D-0333-2024
Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
Class IFDA: OngoingNeptune Resources, LLC
DrugFeb 28, 2024
Insight Pharmaceuticals LLC, a Prestige Consumer TING 1% Tolnaftate Athlete's Foot Spray recall — FDA D-0346-2024
Chemical Contamination; presence of benzene.
Class IFDA: CompletedInsight Pharmaceuticals LLC, a Prestige Consumer…
DrugFeb 28, 2024
Voriconazole for Oral Suspension, 40mg/mL, Orange-Flavored, 49g/75mL when reconstituted recall — FDA D-0337-2024
Labeling: Incorrect or Missing Package Insert
Class IIFDA: TerminatedLupin Pharmaceuticals Inc.
DrugFeb 28, 2024
Norepinephrine Bitartrate in 5% Dextrose Injection, 8 mg/ 250 mL (32 mcg/mL), For recall — FDA D-0336-2024
Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified…
Class IIFDA: OngoingBaxter Healthcare Corporation
DrugFeb 28, 2024
Acthar Gel recall — FDA D-0340-2024
cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
Class IIFDA: OngoingMallinckrodt Hospital Products Inc.
DrugFeb 28, 2024
Neptune Resources Neptune's Fix, Tianeptine Extra Strength Elixir, 0.338 fl oz (10 mL) recall — FDA D-0334-2024
Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
Class IFDA: OngoingNeptune Resources, LLC
DrugFeb 28, 2024
Neptune Resources Neptune's Fix, Tianeptine Tablets Extended Relief, Twenty Tablets per Box recall — FDA D-0335-2024
Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
Class IFDA: OngoingNeptune Resources, LLC
DrugFeb 28, 2024
Today The World Arize Herbal Dietary Supplement recall — FDA D-0345-2024
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared nortadalafil, an ingredient found in FDA approved product for the treatment of male…
Class IFDA: OngoingToday The World
DrugFeb 28, 2024
Bestco Equate Cherry Cough Drops, Menthol cough suppressant/Oral Anesthetic, a) 30 drops per recall — FDA D-0332-2024
CGMP Deviations: Potential Glass and Silicone particulates in product
Class IIFDA: TerminatedBestco LLC
DrugFeb 28, 2024
CABTREO recall — FDA D-0347-2024
CGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated.
Class IIFDA: TerminatedMCKESSON CORPORATION
VehicleFeb 27, 2024
Tacoma axle recall — NHTSA campaign 24V152000
Toyota Motor Engineering & Manufacturer (Toyota) is recalling certain 2022-2023 Tacoma vehicles. The axle shaft sub-assembly may separate from the axle housing due to debris causing…
axleToyota Motor Engineering & Manufacturing
VehicleFeb 27, 2024
Nissan inflator module recall — NHTSA campaign 24V154000
Nissan North America, Inc. (Nissan) is recalling certain 2024 Titan, Frontier, Infiniti QX60, Pathfinder, 2023-2024 Sentra, Versa, Kicks, Infiniti QX50, and 2023 Rogue vehicles. Due to a…
inflator moduleNissan North America, Inc.
VehicleFeb 27, 2024
Tesla external/pedestrian alert recall — NHTSA campaign 24V153000
Tesla, Inc. (Tesla) is recalling certain 2013, 2018-2021 Model S, 2020-2021 Model X, 2018-2022 Model 3, and 2020-2022 Model Y vehicles. A factory reset muted the Pedestrian Warning System…
external/pedestrian alertTesla, Inc.
VehicleFeb 26, 2024
Telluride headlights recall — NHTSA campaign 24V148000
Kia America, Inc. (Kia) is recalling certain 2020 Telluride vehicles. The high beam headlights may fail.
headlightsKia America, Inc.
VehicleFeb 23, 2024
Maverick Hybrid instrument cluster/panel recall — NHTSA campaign 24V140000
Ford Motor Company (Ford) is recalling certain 2022-2023 Maverick Hybrid vehicles. The Instrument Panel Cluster may not properly illuminate warning lights or gauges. As such, these vehicles…
instrument cluster/panelFord Motor Company
VehicleFeb 23, 2024
Ford glass, side/rear recall — NHTSA campaign 24V142000
Ford Motor Company (Ford) is recalling certain 2023-2024 Bronco and Bronco Heritage vehicles. The rear quarter glass panels may have been improperly installed to the vehicle hard top, which…
glass, side/rearFord Motor Company
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026371 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026340 records · 4 categoriesApril 2026415 records · 4 categoriesMarch 2026190 records · 4 categoriesFebruary 2026331 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025388 records · 4 categoriesNovember 2025325 records · 4 categoriesOctober 2025454 records · 4 categoriesSeptember 2025180 records · 4 categories